BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20665672)

  • 1. Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol.
    Shalhoub V; Shatzen EM; Ward SC; Young JI; Boedigheimer M; Twehues L; McNinch J; Scully S; Twomey B; Baker D; Kiaei P; Damore MA; Pan Z; Haas K; Martin D
    J Cell Biochem; 2010 Nov; 111(4):911-21. PubMed ID: 20665672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols.
    Shalhoub V; Shatzen E; Henley C; Boedigheimer M; McNinch J; Manoukian R; Damore M; Fitzpatrick D; Haas K; Twomey B; Kiaei P; Ward S; Lacey DL; Martin D
    Calcif Tissue Int; 2006 Dec; 79(6):431-42. PubMed ID: 17171500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation.
    Martínez-Moreno JM; Muñoz-Castañeda JR; Herencia C; Oca AM; Estepa JC; Canalejo R; Rodríguez-Ortiz ME; Perez-Martinez P; Aguilera-Tejero E; Canalejo A; Rodríguez M; Almadén Y
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1136-44. PubMed ID: 22874762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.
    Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
    J Cell Biochem; 2007 Apr; 100(6):1395-405. PubMed ID: 17115413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells.
    Wu-Wong JR; Nakane M; Ma J
    Thromb Res; 2006; 118(6):709-14. PubMed ID: 16371233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of vitamin D analogs on vascular calcification.
    Cardús A; Panizo S; Parisi E; Fernandez E; Valdivielso JM
    J Bone Miner Res; 2007 Jun; 22(6):860-6. PubMed ID: 17352647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin.
    Li X; Speer MY; Yang H; Bergen J; Giachelli CM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):321-6. PubMed ID: 19948844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells.
    Becs G; Zarjou A; Agarwal A; Kovács KÉ; Becs Á; Nyitrai M; Balogh E; Bányai E; Eaton JW; Arosio P; Poli M; Jeney V; Balla J; Balla G
    J Cell Mol Med; 2016 Feb; 20(2):217-30. PubMed ID: 26499096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APE1/Ref-1 Inhibits Phosphate-Induced Calcification and Osteoblastic Phenotype Changes in Vascular Smooth Muscle Cells.
    Lee KM; Lee EO; Lee YR; Joo HK; Park MS; Kim CS; Choi S; Jeong JO; Jeon BH
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.
    Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1592-604. PubMed ID: 17715259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells.
    Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
    Atherosclerosis; 2006 May; 186(1):20-8. PubMed ID: 16095599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.
    Lau WL; Leaf EM; Hu MC; Takeno MM; Kuro-o M; Moe OW; Giachelli CM
    Kidney Int; 2012 Dec; 82(12):1261-70. PubMed ID: 22932118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells.
    Wu-Wong JR; Nakane M; Ma J
    J Vasc Res; 2007; 44(1):11-8. PubMed ID: 17159355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells.
    Martinez-Moreno JM; Herencia C; Montes de Oca A; Muñoz-Castañeda JR; Rodríguez-Ortiz ME; Díaz-Tocados JM; Peralbo-Santaella E; Camargo A; Canalejo A; Rodriguez M; Velasco-Gimena F; Almaden Y
    FASEB J; 2016 Mar; 30(3):1367-76. PubMed ID: 26700731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol prevents in vitro vascular smooth muscle cell mineralization by regulating calcium-sensing receptor expression.
    Mary A; Hénaut L; Boudot C; Six I; Brazier M; Massy ZA; Drüeke TB; Kamel S; Mentaverri R
    Endocrinology; 2015 Jun; 156(6):1965-74. PubMed ID: 25763635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives.
    Martínez-Moreno JM; Herencia C; de Oca AM; Díaz-Tocados JM; Vergara N; Gómez-Luna MJ; López-Argüello SD; Camargo A; Peralbo-Santaella E; Rodríguez-Ortiz ME; Canalejo A; Rodríguez M; Muñoz-Castañeda JR; Almadén Y
    Clin Sci (Lond); 2017 Jul; 131(13):1449-1463. PubMed ID: 28442557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D analogs down-regulate plasminogen activator inhibitor-1 in human coronary artery smooth muscle cells.
    Ruth Wu-Wong J; Nakane M; Ma J; Cook AL
    J Thromb Haemost; 2005 Jul; 3(7):1545-6. PubMed ID: 15978119
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells.
    Nakahara T; Kawai-Kowase K; Matsui H; Sunaga H; Utsugi T; Iso T; Arai M; Tomono S; Kurabayashi M
    Atherosclerosis; 2016 Oct; 253():102-110. PubMed ID: 27599364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor activators can protect against vascular calcification.
    Mathew S; Lund RJ; Chaudhary LR; Geurs T; Hruska KA
    J Am Soc Nephrol; 2008 Aug; 19(8):1509-19. PubMed ID: 18448587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.
    Mizobuchi M; Finch JL; Martin DR; Slatopolsky E
    Kidney Int; 2007 Sep; 72(6):709-15. PubMed ID: 17597697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.